Engerix B

Engerix B is a vaccine designed to protect against hepatitis B, a viral infection affecting the liver. It contains hepatitis B surface antigen (rDNA) and alum adjuvant, administered via intramuscular injection.

Engerix B is used to prevent hepatitis B infection, which can lead to serious liver damage. This vaccine is typically recommended for individuals at high risk of exposure, such as healthcare workers, travelers to regions with high hepatitis B prevalence, and those with certain medical conditions. It is also used for routine immunization in infants and children to ensure long-term protection.

Common effects of Engerix B may include mild soreness, redness, or swelling at the injection site. Some individuals may experience temporary fatigue, headache, or low-grade fever. These effects are usually mild and resolve within a few days.

Engerix B should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to inform the healthcare provider about any current illnesses or medications before receiving the vaccine.

Engerix B may interact with certain medications or other vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving Engerix B. Alcohol and other substances should be considered, but specific interactions are not well-documented.